Abstract
Sotorasib (LUMAKRAS((TM))) is a RAS GTPase family inhibitor being developed by Amgen for the treatment of solid tumours with KRAS mutations, including......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
